Factors influencing intention to undergo whole genome screening in future healthcare: A single-blind parallel-group randomised trial

Preventive Medicine

Volumn 55, Issue 5, 2012, Pages 514-520

  Fisher, Alana ^a   Bonner, Carissa ^a   Biankin, Andrew V ^b,c,d   Juraskova, Ilona ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Consumer information handout; DNA; Genetic screening; Genome; Individualised medicine; Information disclosure; Psychological models; Screening; Sequence analysis

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ENGLISH AS A SECOND LANGUAGE; GENE SEQUENCE; GENETIC SCREENING; HEALTH CARE; HUMAN; PRIORITY JOURNAL; RANDOMIZATION; SELF CONCEPT; UNCERTAINTY;

ADOLESCENT; ADULT; AUSTRALIA; COST-BENEFIT ANALYSIS; FEMALE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTENTION; MALE; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; SELF EFFICACY; SINGLE-BLIND METHOD; UNCERTAINTY;

EID: 84868303539     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.08.008     Document Type: Article

References (37)

1. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
2. Braithwaite D., Sutton S., Steggles N. Intention to participate in predictive genetic testing for hereditary cancer: the role of Attitude toward Uncertainty. Psychol. Heal. 2002, 17:761-772.
3. Brouwers M.C., Sorrentino R.M. Uncertainty orientation and Protection Motivation Theory: the role of individual differences in health compliance. J. Personal. Soc. Psychol. 1993, 65:102-112.
4. Bunn J.Y., Bosompra K., Ashikaga T., Flynn B.S., Worden J.K. Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study. Prev. Med. 2002, 34:567-577.
5. Cameron L.D., Diefenbach M.A. Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. J. Heal. Psychol. 2001, 6:47-59.
6. Cameron L.D., Muller C. Psychosocial aspects of genetic testing. Curr. Opin. Psychiatr. 2009, 22:218-223.
7. Clarke A., Thirlaway K. Genetic counselling for personalised medicine. Hum. Genet. 2011, 130:27-31.
8. Crockett R.A., Weinman J., Hankins M., Marteau T.M. Time orientation and health-related behaviour: measurement in general population samples. Psychol. Heal. 2009, 24:333-350.
9. Etchegary H. Psychological aspects of predictive genetic-test decisions: what do we know so far?. Anal. Soc. Issues Public Policy 2004, 4:13-31.
10. Frost S., Myers L.B., Newman S.P. Genetic screening for Alzheimer's disease: what factors predict intentions to take a test?. Behav. Med. 2001, 27:101-109.
11. The 'thousand-dollar genome': an ethical exploration. Monitoring Report Ethics and Health 2010, Health Council of the Netherlands, Retrieved March 15, 2011 from http://www.gezondheidsraad.nl/en/publications/thousand-dollar-genome-ethical-exploration.
12. Helmes A.W. Application of the protection motivation theory to genetic testing for breast cancer risk. Prev. Med. 2002, 35:453-462.
13. Hunter D.J., Khoury M.J., Drazen J.M. Letting the genome out of the bottle - will we get our wish?. N. Engl. J. Med. 2008, 358:105-107.
14. Jorgensen K.J., Gotzsche P.C. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ 2004, 328:148.
15. Loewenstein G., Weber E., Hsee C., Welch E. Risk as feelings. Psychol. Bull. 2001, 127:267-286.
16. McBride C.M., Koehly L.M., Sanderson S.C., Kaphingst K.A. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?. Annu. Rev. Publ. Health 2010, 31:89-103.
17. Morrison V., Bennett P., Butow P., Mullan B., White K. An Introduction to Health Psychology in Australia 2008, Pearson Education Australia, Frenchs Forest, NSW. 1st ed.
18. Morrison V., Henderson B.J., Taylor C., Dafydd N.A., Unwin A. The impact of information order on intentions to undergo predictive genetic testing. J. Heal. Psychol. 2010, 15:1082-1092.
19. National Health Medical Research Council Medical Genetic Testing Retrieved March 20, 2011 from. http://www.nhmrc.gov.au/publications/synopses/e99syn.htm.
20. Norman P., Boer H., Seydel E.R. Protection motivation theory. Predicting Health Behaviour 2005, 81-126. Open University Press, Buckingham, Buckingham. 2nd ed. M. Conner, P. Norman (Eds.).
21. O'Neill S., McBride C., Alford S., Kaphingst K. Preferences for genetic and behavioral health information: the impact of risk factors and disease attributions. Ann. Behav. Med. 2010, 40:127-137.
22. O'Daniel J.M. The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. J. Genet. Couns. 2010, 19:315-327.
23. Orbell S., Hagger M. Temporal framing and the decision to take part in type 2 diabetes screening: effects of individual differences in consideration of future consequences on persuasion. Heal. Psychol. 2006, 25:537-548.
24. Orbell S., Perugini M., Rakow T. Individual differences in sensitivity to health communications: consideration of future consequences. Heal. Psychol. 2004, 23:388-396.
25. Pallant J. SPSS Survival Manual 2005, Allen & Unwin, Sydney, Australia. 2nd ed.
26. Robertson J.A. The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. Am. J. Bioeth. 2003, 3:35-42.
27. Rogers R.W. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. Social Psychology: A Sourcebook 1983, 153-176. Guilford Press, New York. J.R. Cacioppo, R.E. Petty (Eds.).
28. Shaw J.S., Bassi K.L. Lay attitudes toward genetic testing for susceptibility to inherited diseases. J. Heal. Psychol. 2001, 6:405-423.
29. Strathman A., Gleicher F., Boninger D.S., Edwards C.S. The consideration of future consequences: weighing immediate and distant outcomes of behavior. J. Personal. Soc. Psychol. 1994, 66:742-752.
30. Sweeny K., Legg A.M. Predictors of interest in direct-to-consumer genetic testing. Psychol. Heal. 2011, 1-14. 10.1080/08870446.2010.514607.
31. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2001, Allyn & Bacon, Needham Heights, United States of America. 4th ed.
32. Webb T.L., Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol. Bull. 2006, 132:249-268.
33. Weinstein N.D. Unrealistic optimism about susceptibility to health problems. J. Behav. Med. 1982, 5:441-460.
34. Weinstein N.D. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J. Behav. Med. 1987, 10:481-500.
35. Weller D.P., Patnick J., McIntosh H.M., Dietrich A.J. Uptake in cancer screening programmes. Lancet Oncol. 2009, 10:693-699.
36. Wolff K., Nordin K., Brun W., Berglund G., Kvale G. Affective and cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: an extension of the Theory of Planned Behaviour. Psychol. Heal. 2011, 2011:1-13.
37. Wright C., Kroese M. Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?. Hum. Genet. 2010, 127:125-134.